Skip to content
OpenCapital
Get started

CRISPR Therapeutics CRSP Quick ratio

Quick ratio at other companies

CG Oncology logo
CG OncologyCGON
31.3×+0.3×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
15.1×+10.0×
Arrowhead Research logo
Arrowhead ResearchARWR
6.2×+1.1×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.1×
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
9.1×-0.2×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
9×+0.9×

Other financials

Income statement

See full
Revenue$1.5M+68.6%
Operating income-$130.2M+12.2%
Net income-$122.9M+9.6%
EPS (diluted)-$1.28+19.0%

Balance sheet

See full
Cash & equivalents$423.3M+80.0%
Total debt$787.6M+259%
Total equity$1.8B-0.8%
Total assets$2.7B+25.8%

Cash flow

See full
Operating cash flow-$108.9M-102%
CapEx$504.0K+145%
Free cash flow-$109.4M-102%

Valuation

See full
Market cap$5.33B+56.4%
Enterprise value$5.69B+69.8%
P/S1,298.3×+1,208×

Profitability

See full
Operating margin-15,754.2%-17,253pp
Net margin-13,856.5%-15,058pp
FCF margin-9,777.6%-10,759pp

Returns & leverage

See full
Return on equity-31.2%+43.7pp
Debt / equity0.4×+0.3×
Current ratio18×+2.3×

Where this comes from

Calculated from CRISPR Therapeutics’s reported figures.

quick assets/total current liabilities=18×

Based on the most recent quarter.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CRISPR Therapeutics's quick ratio?
CRISPR Therapeutics (CRSP) reported quick ratio of 18× in Q1 2026.
How has CRISPR Therapeutics's quick ratio changed year-over-year?
CRISPR Therapeutics's quick ratio increased by 14.9% year-over-year, from 15.6× to 18×.
What is the long-term trend for CRISPR Therapeutics's quick ratio?
Over 5 years (2020 to 2025), CRISPR Therapeutics's quick ratio has grown at a -6.1% compound annual growth rate (CAGR), from 18.2× to 13.3×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.